BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Healthcare | 6.75% |
| 3 | Financials | 5.74% |
| 4 | Consumer Discretionary | 5.28% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
NovaGold Resources
NG
$3.48B
| $665K | ﹤0.01% |
90,110
+29,903
| +50% | +$256K |
|
2052
Urban Edge Properties
UE
$2.76B
| $664K | ﹤0.01% |
75,344
+40,642
| +117% | +$668K |
|
2053
Tenable Holdings
TENB
$4.22B
| $663K | ﹤0.01% |
30,326
+22,387
| +282% | +$554K |
|
2054
Evertec
EVTC
$1.89B
| $661K | ﹤0.01% |
29,098
-23,437
| -45% | -$718K |
|
2055
iShares Europe ETF
IEV
$1.7B
| $660K | ﹤0.01% |
18,688
-3,112
| -14% | -$132K |
|
2056
MPLX
MPLX
$60.3B
| $659K | ﹤0.01% |
56,682
-18,454
| -25% | -$378K |
|
|
BEAT
2057
DELISTED
BioTelemetry, Inc.
BEAT
| $657K | ﹤0.01% |
17,068
+4,776
| +39% | +$220K |
|
2058
Coherus Oncology
CHRS
$185M
| $657K | ﹤0.01% |
40,502
+33,207
| +455% | +$614K |
|
|
IBKC
2059
DELISTED
IBERIABANK Corp
IBKC
| $656K | ﹤0.01% |
18,155
-5,781
| -24% | -$360K |
|
2060
Fate Therapeutics
FATE
$308M
| $654K | ﹤0.01% |
29,452
+22,348
| +315% | +$565K |
|
2061
Westamerica Bancorp
WABC
$1.38B
| $653K | ﹤0.01% |
11,113
+4,593
| +70% | +$286K |
|
2062
AngioDynamics
ANGO
$655M
| $652K | ﹤0.01% |
62,546
+52,929
| +550% | +$664K |
|
2063
Ennis
EBF
$559M
| $652K | ﹤0.01% |
34,705
+28,247
| +437% | +$567K |
|
|
HI
2064
DELISTED
Hillenbrand
HI
| $651K | ﹤0.01% |
34,082
+8,051
| +31% | +$209K |
|
2065
Myriad Genetics
MYGN
$290M
| $651K | ﹤0.01% |
45,497
+24,007
| +112% | +$507K |
|
2066
Brinker International
EAT
$10.2B
| $651K | ﹤0.01% |
54,172
+19,979
| +58% | +$672K |
|
|
KEM
2067
DELISTED
KEMET Corporation
KEM
| $650K | ﹤0.01% |
26,921
+6,441
| +31% | +$163K |
|
2068
HUB Group
HUBG
$2.46B
| $650K | ﹤0.01% |
28,582
-77,100
| -73% | -$1.93M |
|
2069
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$34.8B
| $649K | ﹤0.01% |
110
| – | – |
|
2070
AeroVironment
AVAV
$9.76B
| $648K | ﹤0.01% |
10,627
+2,718
| +34% | +$170K |
|
2071
Stellantis
STLA
$20.2B
| $645K | ﹤0.01% |
89,759
-731,530
| -89% | -$8.67M |
|
2072
Atlantic Union Bankshares
AUB
$6.12B
| $645K | ﹤0.01% |
29,467
+15,709
| +114% | +$487K |
|
2073
BHP
BHP
$220B
| $642K | ﹤0.01% |
19,605
+16,477
| +527% | +$688K |
|
|
SRDX
2074
DELISTED
Surmodics
SRDX
| $642K | ﹤0.01% |
19,255
+16,282
| +548% | +$588K |
|
2075
Dorman Products
DORM
$4.05B
| $641K | ﹤0.01% |
11,599
+3,546
| +44% | +$241K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.